Rhythm Pharmaceuticals buy Guggenheim
Start price
10.07.25
/
50%
€75.50
Target price
10.07.26
-
Performance (%)
0.00%
Price
09:47
?
Summary
This prediction is currently active. Guggenheim's BUY prediction for Rhythm Pharmaceuticals is currently unchanged. This prediction currently runs until 10.07.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.685% | 0.685% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
06.08.25
06.08.25
€103.73
06.08.26
06.08.26
-2.58%
09:47
09:47
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
95.04%
22.10.25
22.10.25